Publications by authors named "Biwei Zhao"

Claim this Profile
I
Implementing Synthetic Multi-Transmembrane Receptor Protein in a Duplex Immunoassay for Assessment of Neutralizing Antibody to a Bispecific Biotherapeutic.
Bonnie Wu, James Devlin, Megan Schnarr, Yingbiao Ji, Biwei Zhao

AAPS J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrathin Ce-doped LaOnanofilm electrocatalysts for efficient oxygen evolution reactions.
Guangyuan Yan, Tong Wu, Shuming Xing, Fei Chen, Biwei Zhao

Nanotechnology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast Dissolving of Ferulic Acid via Electrospun Ternary Amorphous Composites Produced by a Coaxial Process.
Weidong Huang, Yaoyao Yang, Biwei Zhao, Gangqiang Liang, Shiwei Liu

Pharmaceutics· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab.
Venky Ramakrishna, Karuna Sundarapandiyan, Biwei Zhao, Max Bylesjo, Henry C Marsh

J Immunother Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.
Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, Ding Wang, Richard D Carvajal

Sci Transl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue.
Amita Joshi, Biwei Zhao, Cara Romanowski, David Rosen, Phyllis Flomenberg

PLoS One· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.
Michael A Morse, Robert Chapman, John Powderly, Kimberly Blackwell, Tibor Keler, Biwei Zhao

Clin Cancer Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E1A is the component of the MHC class I enhancer complex that mediates HDAC chromatin repression in adenovirus-12 tumorigenic cells.
Biwei Zhao, Robert P Ricciardi

Virology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin repression by COUP-TFII and HDAC dominates activation by NF-kappaB in regulating major histocompatibility complex class I transcription in adenovirus tumorigenic cells.
Biwei Zhao, Shihe Hou, Robert P Ricciardi

Virology· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis